A partner in the UK firm, Mr. Stirling was previously head of KPMG’s Chemicals and Pharmaceuticals practice for Europe, the Middle East and Africa region. His career spans over 30 years; he has worked in numerous countries across KPMG’s global network, and he held leadership positions in both the Audit and Advisory practices.
Mr. Stirling has been the lead partner on a number of large global audits in the sector and, as one of the founding partners of KPMG’s Transaction Services practice has been involved in some of the largest and most complex cross-border transactions in the Life Sciences sector. Mr. Stirling is a regular contributor to industry debates, attending global conferences and commenting on issues affecting the Life Sciences sector.
“The life sciences industry is at a pivotal point in its evolution,” said Mr. Stirling. “With dramatic shifts in the world’s demographics, uncertain economic conditions and huge pressures on healthcare systems around the world, the life sciences and pharmaceutical sector in particular, must adjust their business models to meet new and uncharted challenges. Moreover, burgeoning developments in life sciences are presenting some amazing opportunities for growth and KPMG firms plan to help to clients be at the forefront of innovation in these areas.”
Isabelle Allen, KPMG’s Global Head of Sales & Markets, said, “Chris brings a wealth of experience to this dynamic sector. As we continue to evolve this practice to align with the new business landscape and the challenges life sciences companies are facing, Chris’ passion for the sector and deep knowledge of KPMG firms’ global capability will offer substantial benefits to clients.”
For further information, contact:
Jennifer Samuel
Head of External Communications, Global Industries
KPMG International
Tel: +1 416 777 8491
KPMG’s Life Sciences practice offers audit, tax, advisory and transaction services to a broad array of member firms’ (RC) clients involved in utilizing and advancing science to improve the quality of life for human beings and animals. KPMG’s portfolio of services includes but is not limited to serving clients in animal health, biotechnology, medical devices & diagnostics, pharmaceuticals, plant sciences and vaccines.
About KPMG
KPMG is a global network of professional firms providing Audit, Tax and Advisory services. We operate in 152 countries and have 145,000 people working in member firms around the world. The independent member firms of the KPMG network are affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. Each KPMG firm is a legally distinct and separate entity and describes itself as such.